During the past decade, VRF Eye Specialty Group conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VRF Eye Specialty Group" #1 sponsor was "Santen Inc." with 3 trials, followed by "Aerie Pharmaceuticals" with 2 trials sponsored, "Surface Ophthalmics, Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored and "EyePoint Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "VRF Eye Specialty Group" are "Ocular Hypertension" (3 trials), "Glaucoma, Open-Angle" (2 trials), "Cataract" (1 trials), "Dry Eye Disease" (1 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "VRF Eye Specialty Group" in a lesser frequency.

Most popular intervention types in "VRF Eye Specialty Group" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DE-117 Ophthalmic Solution" (2 trials), "Active Comparator: Timolol 0.5%" (1 trials), "Betamethasone Sodium Phosphate 0.01%" (1 trials), "Bimatoprost SR" (1 trials) and "Cyclosporine 0.05% Ophthalmic Emulsion" (1 trials). Other intervention names were less common.

The vast majority of trials in "VRF Eye Specialty Group" are 9 trials for "All" genders.

Currently, there are NaN active trials in "VRF Eye Specialty Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in VRF Eye Specialty Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VRF Eye Specialty Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".